These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5742168)

  • 1. [Measles vaccination (1): take on development of the inactivated vaccine].
    Gard S
    Lakartidningen; 1968 Dec; 65(49):4897-904. PubMed ID: 5742168
    [No Abstract]   [Full Text] [Related]  

  • 2. [Measles today].
    Feo F; Angela GC
    Minerva Med; 1966 Mar; 57(22):954-73. PubMed ID: 5948625
    [No Abstract]   [Full Text] [Related]  

  • 3. [History of purification, attenuation and testing a measles vaccine made from the strain "Leningrad-16" (L-16)].
    Smorodintsev AA; Taros LIu
    Tr Inst Im Pastera; 1992; 67():86-95. PubMed ID: 8539772
    [No Abstract]   [Full Text] [Related]  

  • 4. [Seroconversion following vaccination with a new measles vaccine strain].
    Just M; Wegmann A
    Ther Umsch; 1983 Mar; 40(3):261-3. PubMed ID: 6857567
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of the immunogenic activity of 2 variants of the measles virus].
    Chiarini A; Brancato P; Sinatra A
    Riv Ist Sieroter Ital; 1968; 43(4):175-88. PubMed ID: 5747129
    [No Abstract]   [Full Text] [Related]  

  • 6. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Age-dependence of measles immunization failures].
    Giesecke H; Brendel P; Schmidt J; Schlenk B
    Z Gesamte Hyg; 1980; 26(10):764-67. PubMed ID: 7467503
    [No Abstract]   [Full Text] [Related]  

  • 9. [Laboratory diagnosis of measles].
    Tóth M
    Orv Hetil; 1970 Feb; 111(7):379-83. PubMed ID: 5415502
    [No Abstract]   [Full Text] [Related]  

  • 10. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
    Dilraj A; Sukhoo R; Cutts FT; Bennett JV
    Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waning immunity and subclinical measles infections in England.
    Glass K; Grenfell BT
    Vaccine; 2004 Sep; 22(29-30):4110-6. PubMed ID: 15364464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal age for vaccinating Nigerian children against measles. II. Seroconversion to measles vaccine in different age groups.
    Ogunmekan DA; Harry TO
    Trop Geogr Med; 1981 Dec; 33(4):379-82. PubMed ID: 7342385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Unsuitability of children revaccination against measles].
    Bolotovskiĭ VM; Titova NS
    Sov Med; 1981; (9):43-8. PubMed ID: 7313794
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.
    Iankov ID; Pandey M; Harvey M; Griesmann GE; Federspiel MJ; Russell SJ
    J Virol; 2006 Sep; 80(17):8530-40. PubMed ID: 16912303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
    J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of immunosuppression on morphological changes in CNS of monkeys infected with different measles virus vaccine strains.
    Sharova OK; Rozina EE; Gordienko NM; Shteinberg LS
    Acta Virol; 1984 Mar; 28(2):144-7. PubMed ID: 6145348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the subclinical infection of the recipients of measles vaccine].
    Wu T; Wang SL; Xiang YZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1996 Apr; 17(2):70-2. PubMed ID: 8758397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severity of measles among patients with incidental postexposure vaccination.
    Sakuta H; Sawada S; Kuroki Y
    Jpn J Infect Dis; 2008 Jul; 61(4):304-6. PubMed ID: 18653975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosol measles vaccination in macaques: preclinical studies of immune responses and safety.
    de Swart RL; Kuiken T; Fernandez-de Castro J; Papania MJ; Bennett JV; Valdespino JL; Minor P; Witham CL; Yüksel S; Vos H; van Amerongen G; Osterhaus AD
    Vaccine; 2006 Sep; 24(40-41):6424-36. PubMed ID: 16934375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.